Filing Details
- Accession Number:
- 0001549084-22-000060
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-10-26 18:31:09
- Reporting Period:
- 2022-10-21
- Accepted Time:
- 2022-10-26 18:31:09
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1549084 | Ekso Bionics Holdings Inc. | EKSO | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1201619 | Steven Sherman | C/O Ekso Bionics Holdings, Inc. 101 Glacier Point, Suite A San Rafael CA 94901 | Ceo & Chairman | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-10-21 | 15,600 | $0.00 | 704,151 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-10-24 | 5,921 | $1.29 | 698,230 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Restricted Stock Units | Disposition | 2022-10-21 | 15,600 | $0.00 | 15,600 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
46,798 | No | 4 | M | Direct |
Footnotes
- Represents shares sold by the Reporting Person on October 24, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of the ninth installment of a restricted stock award originally reported by the Reporting Person in Form 4 filed with the Commission on March 10, 2022
- These shares were sold in a single transaction at a price of $1.2868 per share.
- The restricted stock units ("RSUs") were granted on March 8, 2022 in accordance with the terms of an Executive Employment Agreement entered into between the Reporting Person and the Company on January 21, 2022 (the "Effective Date").
- The RSUs vest in twelve equal installments on the first twelve monthly anniversaries of the Effective Date, starting February 21, 2022, such that the RSUs will be fully vested as of January 21, 2023. The ninth installment of RSUs vested on October 21, 2022 and were delivered to the Reporting Person upon settlement.